» Articles » PMID: 24055063

Autoimmune Polyendocrine Syndromes

Overview
Journal Autoimmun Rev
Publisher Elsevier
Date 2013 Sep 24
PMID 24055063
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune polyendocrine syndromes (APS), also called polyglandular autoimmune syndromes (PGAS), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organs, although non-endocrine organs can be affected. The two major autoimmune polyendocrine syndromes, (type1-type2/APS-1 and APS-2), both have Addison's disease as a prominent component. Further autoimmune polyendocrine syndromes include APS3 and APS4. The major autoimmune polyendocrine syndromes have a strong genetic component with the type 2 syndrome occurring in multiple generations and the type I syndrome in siblings. It is well recognized that more than 20years may elapse between the onset on one endocrinopathy and the diagnosis of the next, for example, almost 40-50% of subjects with Addison's disease will develop an associated endocrinopathy. The discovery of the polyendocrine autoimmune syndromes offered the possibility to understand autoimmune disorders with particular interest for type 1A diabetes and the neuroendocrine immunology (NEI) is further contributing to understand the links.

Citing Articles

Schmidt´s syndrome found by tan: a case report.

Venade G, Almeida C, Oliveira N, Matos L Pan Afr Med J. 2024; 48:53.

PMID: 39315067 PMC: 11419569. DOI: 10.11604/pamj.2024.48.53.35130.


Autoimmune adrenal insufficiency in children: a hint for polyglandular syndrome type 2?.

Arrigoni M, Cavarzere P, Nicolussi Principe L, Gaudino R, Antoniazzi F Ital J Pediatr. 2023; 49(1):94.

PMID: 37516895 PMC: 10387197. DOI: 10.1186/s13052-023-01502-y.


Predicting the risk of autoimmune thyroid disease in patients with vitiligo: Development and assessment of a new predictive nomogram.

Ma Z, Cai M, Yang K, Liu J, Guo T, Liu X Front Endocrinol (Lausanne). 2023; 14:1109925.

PMID: 36798661 PMC: 9927026. DOI: 10.3389/fendo.2023.1109925.


Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario.

Calvete O, Reyes J, Valdes-Socin H, Martin P, Marazuela M, Barroso A Cells. 2021; 10(12).

PMID: 34944008 PMC: 8700745. DOI: 10.3390/cells10123500.


Primary Adrenal Insufficiency After COVID-19 Infection.

Sanchez J, Cohen M, Zapater J, Eisenberg Y AACE Clin Case Rep. 2021; 8(2):51-53.

PMID: 34805497 PMC: 8590605. DOI: 10.1016/j.aace.2021.11.001.